Correlation Between Syndax Pharmaceuticals and Relay Therapeutics
Can any of the company-specific risk be diversified away by investing in both Syndax Pharmaceuticals and Relay Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Syndax Pharmaceuticals and Relay Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Syndax Pharmaceuticals and Relay Therapeutics, you can compare the effects of market volatilities on Syndax Pharmaceuticals and Relay Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Syndax Pharmaceuticals with a short position of Relay Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Syndax Pharmaceuticals and Relay Therapeutics.
Diversification Opportunities for Syndax Pharmaceuticals and Relay Therapeutics
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Syndax and Relay is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Syndax Pharmaceuticals and Relay Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relay Therapeutics and Syndax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Syndax Pharmaceuticals are associated (or correlated) with Relay Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relay Therapeutics has no effect on the direction of Syndax Pharmaceuticals i.e., Syndax Pharmaceuticals and Relay Therapeutics go up and down completely randomly.
Pair Corralation between Syndax Pharmaceuticals and Relay Therapeutics
Given the investment horizon of 90 days Syndax Pharmaceuticals is expected to generate 0.55 times more return on investment than Relay Therapeutics. However, Syndax Pharmaceuticals is 1.81 times less risky than Relay Therapeutics. It trades about -0.05 of its potential returns per unit of risk. Relay Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 2,054 in Syndax Pharmaceuticals on September 3, 2024 and sell it today you would lose (382.00) from holding Syndax Pharmaceuticals or give up 18.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Syndax Pharmaceuticals vs. Relay Therapeutics
Performance |
| Timeline |
| Syndax Pharmaceuticals |
| Relay Therapeutics |
Syndax Pharmaceuticals and Relay Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Syndax Pharmaceuticals and Relay Therapeutics
The main advantage of trading using opposite Syndax Pharmaceuticals and Relay Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Syndax Pharmaceuticals position performs unexpectedly, Relay Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relay Therapeutics will offset losses from the drop in Relay Therapeutics' long position.| Syndax Pharmaceuticals vs. Cogent Biosciences | Syndax Pharmaceuticals vs. Cullinan Oncology LLC | Syndax Pharmaceuticals vs. Kalvista Pharmaceuticals | Syndax Pharmaceuticals vs. Mersana Therapeutics |
| Relay Therapeutics vs. Stoke Therapeutics | Relay Therapeutics vs. Pliant Therapeutics | Relay Therapeutics vs. Black Diamond Therapeutics | Relay Therapeutics vs. Arvinas |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |